Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
119 studies found for:    "Sclerosis" AND (woman OR women OR female)
Show Display Options
Rank Status Study
1 Completed Exercises for Urinary Incontinence(UI) of Women With Multiple Sclerosis (MS)
Conditions: Urinary Incontinence;;   Multiple Sclerosis
Intervention: Behavioral: Paula method
2 Not yet recruiting Immune Profiling During Ocrelizumab Treatment in Multiple Sclerosis
Conditions: Multiple Sclerosis;   Healthy
Interventions: Other: Blood sampling (MS);   Other: Blood sampling (controls)
3 Recruiting Teriflunomide Male Transmission Study
Condition: Multiple Sclerosis
Intervention:
4 Recruiting Genes and Environment in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
5 Recruiting A TSEC for Symptom Management in Menopausal Women With Multiple Sclerosis
Conditions: Menopause;   Multiple Sclerosis
Interventions: Drug: Tissue Selective Estrogen Complex;   Drug: Placebo
6 Recruiting Microglial Activation Positron Emission Tomography (PET) Brain Imaging in Multiple Sclerosis and Alzheimer's Disease
Conditions: Multiple Sclerosis;   Alzheimer's Disease
Intervention: Drug: [F-18]PBR06
7 Completed Role of Neuromuscular Junction Function in Motor Fatigue in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
8 Recruiting Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition
Conditions: Relapsing-remitting Multiple Sclerosis;   Secondary-progressive Multiple Sclerosis;   Primary-progressive Multiple Sclerosis
Interventions: Drug: estriol;   Other: Placebo;   Drug: Norethindrone;   Other: Progestin Placebo
9 Recruiting A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis
Condition: Progressive Multiple Sclerosis
Interventions: Drug: GZ402668;   Drug: Placebo;   Drug: Acyclovir
10 Completed A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis
Condition: Progressive Multiple Sclerosis
Interventions: Drug: GZ402668;   Drug: placebo;   Drug: acyclovir
11 Completed Changes in Speed, Endurance and Balance in Women Patients With Multiple Sclerosis After 4 & 8 Weeks of Aquatic Exercise Training
Conditions: Multiple Sclerosis;   Aquatic;   Exercise
Interventions: Behavioral: Exercise;   Behavioral: Control
12 Completed Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction
Condition: Systemic Sclerosis
Intervention: Drug: Cialis
13 Completed AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS
Conditions: Multiple Sclerosis;   Clinically Isolated Syndrome
Intervention:
14 Completed Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: firategrast
15 Completed Treatment of Multiple Sclerosis With Copaxone and Albuterol
Conditions: Autoimmune Diseases;   Multiple Sclerosis
Interventions: Drug: Glatiramer acetate;   Drug: Albuterol;   Drug: Albuterol placebo
16 Completed Safety of RG2077 in Patients With Multiple Sclerosis
Conditions: Multiple Sclerosis;   Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: RG2077 (CTLA4-IgG4m)
17 Terminated Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor
Condition: Multiple Sclerosis (MS) - Relapsing-remitting
Intervention: Biological: sirolimus
18 Recruiting Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
Condition: Relapsing Remitting Multiple Sclerosis
Intervention:
19 Completed Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Intervention: Drug: firategrast (SB683699)
20 Completed ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.
Condition: Multiple Sclerosis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.